Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

RTTNews | 963 dagar sedan
Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

(RTTNews) - Incyte Corp. (INCY) announced Friday that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD) use in the treatment of certain types of myelofibrosis (MF), polycythemia vera (PV) and graft-versus-host disease (GVHD).

The complete response letter states that the FDA cannot approve the application in its present form. The FDA acknowledged that the study submitted in the New Drug Application (NDA) met its objective of bioequivalence based on area under the curve (AUC) parameters but identified additional requirements for approval.

Incyte intends to meet with the FDA to determine appropriate next steps.

The NDA was based on two studies designed to show that ruxolitinib XR tablets are dosage strength proportional and bioequivalent to Jakafi (ruxolitinib) tablets.

read more
Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Corp. (INCY) on Tuesday reported net income of $201.10 million or $0.89 per share for the fourth quarter, sharply higher than $28.46 million or $0.13 per share in the prior-year quarter.
RTTNews | 637 dagar sedan
Incyte Q1 Results Top Estimates

Incyte Q1 Results Top Estimates

Incyte Corp. (INCY) on Tuesday reported net income of $161.43 million or $0.72 per share for the first quarter, up from $149.46 million or $0.67 per share in the prior-year quarter.
RTTNews | 1197 dagar sedan
Sensex, Nifty Extend Gains As IT Stocks Surge

Sensex, Nifty Extend Gains As IT Stocks Surge

Indian shares opened on a buoyant note Wednesday, with IT stocks surging amid positive global cues and on growing optimism over a potential trade deal with the United States.
RTTNews | 1h 51minuter sedan
Australian Market Extends Early Gains In Mid-market

Australian Market Extends Early Gains In Mid-market

The Australian stock market is extending its early gains in mid-market moves on Wednesday, reversing the losses in the previous session, with the benchmark S&P/ASX 200 staying well above the 8,800 level, following the mixed cues from Wall Street overnight, with gains in mining and energy stocks partially offset by weakness in technology stocks.
RTTNews | 3h 17minuter sedan
Asian Markets A Sea Of Green

Asian Markets A Sea Of Green

Asian stock markets are a sea of green on Wednesday, following the mixed cues from Wall Street overnight, amid optimism about an end to the record-setting U.S. government shutdown of 42 days and expectations of the US Fed cutting interest-rate next month. Traders largely shrugged off worries about the economic impact of the shutdown. Asian markets closed mixed on Tuesday.
RTTNews | 3h 23minuter sedan
Sensex, Nifty Seen Higher At Open

Sensex, Nifty Seen Higher At Open

Indian shares are seen opening a tad higher on Wednesday, tracking mostly positive cues from global markets.
RTTNews | 3h 55minuter sedan
Mild Rebound Anticipated For Thai Stock Market

Mild Rebound Anticipated For Thai Stock Market

The Thai stock market has alternated between positive and negative finishes through the last four trading days since the end of the five-day losing streak in which it had dropped more than 15 points or 1.2 percent. The Stock Exchange of Thailand now sits just above the 1,300-point plateau although it's expected to move back to the upside again on Wednesday.
RTTNews | 4h 31minuter sedan
Indonesia Shares Poised To End Losing Streak

Indonesia Shares Poised To End Losing Streak

The Indonesia stock market has moved lower in back-to-back sessions, slumping almost 30 points or 0.4 percent along the way. The Jakarta Composite Index now sits just above the 8,360-point plateau although it's expected to find traction on Wednesday.
RTTNews | 5h 1minuter sedan